BIOMAT Database Logo BIOMAT Database Logo

Bleomycin, cisplatin and etoposide combination therapy (BCE) in drug-resistant gestational choriocarcinoma. 1988

T Yamamoto, and S Sawada, and M Urabe, and N Tamura, and H Suzuki, and K Iwasaku, and J Sasaki, and K Naitoh, and M Fukuoka, and H Okada

UI MeSH Term Description Entries
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011252 Pregnancy Complications, Neoplastic The co-occurrence of pregnancy and NEOPLASMS. The neoplastic disease may precede or follow FERTILIZATION. Complications, Neoplastic Pregnancy,Neoplastic Pregnancy Complications,Pregnancy, Neoplastic Complications,Complication, Neoplastic Pregnancy,Neoplastic Pregnancy Complication,Pregnancies, Neoplastic Complications,Pregnancy Complication, Neoplastic
D001761 Bleomycin A complex of related glycopeptide antibiotics from Streptomyces verticillus consisting of bleomycin A2 and B2. It inhibits DNA metabolism and is used as an antineoplastic, especially for solid tumors. BLEO-cell,Blanoxan,Blenoxane,Bleolem,Bleomicina,Bleomycin A(2),Bleomycin A2,Bleomycin B(2),Bleomycin B2,Bleomycin Sulfate,Bleomycins,Bleomycinum Mack,Bléomycine Bellon,BLEO cell,BLEOcell,Bellon, Bléomycine,Mack, Bleomycinum,Sulfate, Bleomycin
D002822 Choriocarcinoma A malignant metastatic form of trophoblastic tumors. Unlike the HYDATIDIFORM MOLE, choriocarcinoma contains no CHORIONIC VILLI but rather sheets of undifferentiated cytotrophoblasts and syncytiotrophoblasts (TROPHOBLASTS). It is characterized by the large amounts of CHORIONIC GONADOTROPIN produced. Tissue origins can be determined by DNA analyses: placental (fetal) origin or non-placental origin (CHORIOCARCINOMA, NON-GESTATIONAL). Choriocarcinomas
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D005047 Etoposide A semisynthetic derivative of PODOPHYLLOTOXIN that exhibits antitumor activity. Etoposide inhibits DNA synthesis by forming a complex with topoisomerase II and DNA. This complex induces breaks in double stranded DNA and prevents repair by topoisomerase II binding. Accumulated breaks in DNA prevent entry into the mitotic phase of cell division, and lead to cell death. Etoposide acts primarily in the G2 and S phases of the cell cycle. Demethyl Epipodophyllotoxin Ethylidine Glucoside,Celltop,Eposide,Eposin,Eto-GRY,Etomedac,Etopos,Etoposide Pierre Fabre,Etoposide Teva,Etoposide, (5S)-Isomer,Etoposide, (5a alpha)-Isomer,Etoposide, (5a alpha,9 alpha)-Isomer,Etoposide, alpha-D-Glucopyranosyl Isomer,Etoposido Ferrer Farma,Exitop,Lastet,NSC-141540,Onkoposid,Riboposid,Toposar,VP 16-213,VP-16,Vepesid,Vépéside-Sandoz,Eto GRY,Etoposide, alpha D Glucopyranosyl Isomer,NSC 141540,NSC141540,Teva, Etoposide,VP 16,VP 16 213,VP 16213,VP16,Vépéside Sandoz,alpha-D-Glucopyranosyl Isomer Etoposide
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

T Yamamoto, and S Sawada, and M Urabe, and N Tamura, and H Suzuki, and K Iwasaku, and J Sasaki, and K Naitoh, and M Fukuoka, and H Okada
Treatment of drug-tolerant choriocarcinoma in combination with bleomycin, cisplatin and VP16-213 (Etoposide).
June 1986, Asia-Oceania journal of obstetrics and gynaecology,
T Yamamoto, and S Sawada, and M Urabe, and N Tamura, and H Suzuki, and K Iwasaku, and J Sasaki, and K Naitoh, and M Fukuoka, and H Okada
PEBA regimen (cisplatin, etoposide, bleomycin, and adriamycin) in the treatment of drug-resistant choriocarcinoma.
February 1995, Gynecologic oncology,
T Yamamoto, and S Sawada, and M Urabe, and N Tamura, and H Suzuki, and K Iwasaku, and J Sasaki, and K Naitoh, and M Fukuoka, and H Okada
Cisplatin, vinblastine, and bleomycin combination therapy in resistant gestational trophoblastic disease.
October 1986, Cancer,
T Yamamoto, and S Sawada, and M Urabe, and N Tamura, and H Suzuki, and K Iwasaku, and J Sasaki, and K Naitoh, and M Fukuoka, and H Okada
Resistant gestational choriocarcinoma: successful treatment with vinblastine, bleomycin, and cisplatin (VBP).
April 1983, Cancer treatment reports,
T Yamamoto, and S Sawada, and M Urabe, and N Tamura, and H Suzuki, and K Iwasaku, and J Sasaki, and K Naitoh, and M Fukuoka, and H Okada
Etoposide, methotrexate, and bleomycin in drug-resistant gestational trophoblastic disease.
May 1986, Gynecologic oncology,
T Yamamoto, and S Sawada, and M Urabe, and N Tamura, and H Suzuki, and K Iwasaku, and J Sasaki, and K Naitoh, and M Fukuoka, and H Okada
Chemotherapy-resistant gestational trophoblastic neoplasia treated successfully with cisplatin, etoposide, and bleomycin.
March 1988, Obstetrics and gynecology,
T Yamamoto, and S Sawada, and M Urabe, and N Tamura, and H Suzuki, and K Iwasaku, and J Sasaki, and K Naitoh, and M Fukuoka, and H Okada
Long-term remission of previously resistant choriocarcinoma with a combination of etoposide, ifosfamide, and cisplatin.
May 1995, Gynecologic oncology,
T Yamamoto, and S Sawada, and M Urabe, and N Tamura, and H Suzuki, and K Iwasaku, and J Sasaki, and K Naitoh, and M Fukuoka, and H Okada
Cisplatin, vinblastine, and bleomycin combination in the treatment of resistant high-risk gestational trophoblastic tumors.
November 1989, Cancer,
T Yamamoto, and S Sawada, and M Urabe, and N Tamura, and H Suzuki, and K Iwasaku, and J Sasaki, and K Naitoh, and M Fukuoka, and H Okada
[BEP (bleomycin, etoposide, cisplatin) therapy for testicular tumors].
October 1992, Hinyokika kiyo. Acta urologica Japonica,
T Yamamoto, and S Sawada, and M Urabe, and N Tamura, and H Suzuki, and K Iwasaku, and J Sasaki, and K Naitoh, and M Fukuoka, and H Okada
Treatment of resistant non-Hodgkin's lymphomas with cisplatin, etoposide, and bleomycin.
January 1990, Cancer chemotherapy and pharmacology,
Copied contents to your clipboard!